Beilstein J. Org. Chem.2018,14, 2838–2845, doi:10.3762/bjoc.14.262
; enzyme; 13α-estrone; Hirao reaction; 17β-HSD1inhibition; OATP2B1; STS; Introduction
The biosynthesis of estrogens occurs via various enzymatic routes. Cytochrome P450 aromatase catalyzes the conversion of nonaromatic steroids to estrogens [1]. Moreover, hydrolysis of estrone 3-sulfate, existing as a
reactiona of 2- or 4-bromo-13α-estrones 1–6 with diethyl phosphite (7a) or diphenylphosphine oxide (7b).
OATP2B1, STS and 17β-HSD1inhibition data of C–P coupled products 8–13 and their basic compounds 13αE1OMe, 13αE1OH, 13αE1OBn.
Supporting Information
Supporting Information File 378: General synthetic
PDF
Graphical Abstract
Scheme 1:
Pd-catalyzed C(sp2)–P couplings at C-2 or C-4 in the 13α-estrone series.
Beilstein J. Org. Chem.2017,13, 1303–1309, doi:10.3762/bjoc.13.126
17β-HSD1 inhibitors, displaying submicromolar IC50 values.
Keywords: benzofuran; 13α-estrone; 17β-HSD1inhibition; partial saturation; Sonogashira coupling; Introduction
Synthetic modifications of the naturally occurring female prehormone estrone may lead to compounds with diverse biological
compounds may provide promising candidates for drug development in order to get nanomolar inhibitors.
Syntheses of 2- or 4-phenethynyl-13α-estrones (8–11) by Sonogashira coupling.
Partial or full hydrogenation of compounds 8c–11c.
17β-HSD1inhibition data of Sonogashira coupled compounds and their
PDF
Graphical Abstract
Scheme 1:
Syntheses of 2- or 4-phenethynyl-13α-estrones (8–11) by Sonogashira coupling.